Decision to list medical devices supplied by 3M New Zealand Limited and Protec Solutions Limited
Source: Pharmac What we’re doing We are pleased to announce the approval of non-exclusive listing agreements with 3M New Zealand Limited (“3M”) and Protec Solutions Limited (“Protec”) for the supply of continence and urology products to DHBs. In summary, this will result in: 3M’s continence products being listed in Part III of Section H of […]
Read More →Decision to list medical devices in the endomechanical and electrosurgical category supplied by Ortho Medics Limited
Source: Pharmac Our response to what you told us We appreciate the time people took to respond to this consultation. A summary of the main themes raised in feedback and our responses to the feedback received are set out below: Theme Comment Feedback that no technical or resource impacts are expected as a result of […]
Read More →Proposal to list obstetrics and gynaecology products supplied by Pro-Med Technologies Limited
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of obstetrics and gynaecology products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019 through a provisional agreement with Pro-Med Technologies Limited (“ProMed”). Consultation closes at 4pm on Thursday, 6 June 2019 and feedback […]
Read More →Proposal to list continence products supplied by Smith & Nephew Limited
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of continence products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through a listing agreement with Smith & Nephew Limited (“Smith & Nephew”). Consultation closes at 4pm on Friday, 31 May 2019 and […]
Read More →RFP – supply of apomorphine hydrochloride, infusion pumps, dedicated pump syringes (if applicable) and associated consumables
Source: Pharmac PHARMAC invites proposals for the supply of apomorphine hydrochloride in New Zealand. PHARMAC invites proposals for the supply in New Zealand of apomorphine hydrochloride (that allows for both intermittent dosing regimens and continuous subcutaneous infusions) (Apomorphine), ambulatory infusion pumps and dedicated pump syringes (if applicable) (Infusion Pumps) and associated consumables (as described at 3(d) […]
Read More →Decision to list patient warming and cooling medical devices supplied by Bard Australia PTY. Limited
Source: Pharmac Our response to what you told us We appreciate the time people took to review this consultation. A summary of the main themes raised in feedback and our responses to the feedback received are set out below: Theme PHARMAC Comment No technical or resource impacts anticipated for Ministry of Health. Noted. If you […]
Read More →Proposal for changes to funded vaccines in the National Immunisation Schedule
Source: Pharmac Details about our proposal The current funding criteria applying to all vaccines can be found in Section I and Section H of the Pharmaceutical Schedule and would be amended to implement any changes to eligibility and/or the number of doses, should these proposals be accepted. Details about individual products in this proposal can […]
Read More →Decision to list medical devices in the interventional radiology category supplied by Merit Medical Ltd
Source: Pharmac What we are doing We are pleased to announce the approval of a listing agreement for medical devices with Merit Medical Limited (‘Merit’). In summary this will result in: 1427 medical devices from Merit in the interventional radiology category, being listed on the Pharmaceutical Schedule from 1 July 2019 under national agreements that […]
Read More →Decision to list a new brand of labetalol
Source: Pharmac What we are doing PHARMAC has made a decision to fund a new brand of labetalol tablets (Presolol). This is to replace the currently funded brand of labetalol tablets (Hybloc), which is being discontinued by its supplier. Presolol has not been registered by Medsafe. PHARMAC is working to secure supply of a registered […]
Read More →Proposal to list a range of orthopaedic implants and associated products supplied by Medartis New Zealand Ltd and Pioneer Medical Limited
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated products (“Orthopaedic Products”) in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through provisional agreements with Medartis New Zealand Ltd (“Medartis”) and Pioneer Medical Limited (“Pioneer”). Consultation closes at […]
Read More →Decision to list medical devices in the interventional radiology category supplied by Obex Medical Ltd
Source: Pharmac Our response to what you told us We appreciate the time people took to respond to this consultation. A summary of the main themes raised in feedback and our responses to the feedback received are set out below: Theme PHARMAC Staff Comment Feedback that no technical or resource impacts are expected as a […]
Read More →Decision to list interventional radiology products supplied by Obex Medical Ltd
Source: Pharmac Our response to what you told us We appreciate the time people took to respond to this consultation. A summary of the main themes raised in feedback and our responses to the feedback received are set out below: Theme PHARMAC Staff Comment Feedback that no technical or resource impacts are expected as a […]
Read More →Decision to list needles and syringes products supplied by Becton Dickinson Limited and Terumo Australia Pty Limited
Source: Pharmac What we are doing We are pleased to announce the approval of two non-exclusive listing agreements (“Agreements”) with Becton Dickinson Limited (“BD“) and Terumo Australia Pty Limited (“Terumo”) for the supply of needle and syringe products to DHBs. In summary this will result in: BD’s needle and syringe products being listed in Part […]
Read More →Decision to list continence products supplied by Downs Distributors Limited
Source: Pharmac Detail about this decision In May 2018, PHARMAC issued a request for proposals (“RFP”) for the supply of urology, ostomy and continence products to DHBs. The RFP requested proposals for non-exclusive national agreements for listing on the Pharmaceutical Schedule. After evaluating Downs’ proposal, and consulting on the provisional agreement reached, PHARMAC has decided to […]
Read More →April 2019 tender notification
Source: Pharmac PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing […]
Read More →Proposal to decline inactive applications
Source: Pharmac Details about our proposal We have identified inactive funding applications for eight different medicines that we are proposing to decline, for reasons that are explained in detail below. PHARMAC has not yet made a decision about these funding applications. Before we do, we want to hear from people and communities about whether it […]
Read More →Proposal to list patient warming and cooling products supplied by Draeger New Zealand Limited
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of patient warming and cooling products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through a non-exclusive provisional agreement with Draeger New Zealand Limited (“Draeger”). Consultation closes at 4pm on Friday 17 May […]
Read More →Proposal to list surgical suction, chest and wound drainage products supplied by Culpan Distributors Limited
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of surgical suction, chest and wound drainage products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019 through a provisional Agreement with Culpan Distributors Limited (“Culpan”). Consultation closes at 4pm on Friday 17 May […]
Read More →Decision to list various medical devices supplied by REM Systems Ltd
Source: Pharmac Detail about this decision In 2018 PHARMAC issued Requests for Proposals (“RFPs”) for: The RFPs were for non-exclusive national agreements for listing in the Pharmaceutical Schedule. After completing the RFP evaluation processes and consulting on the provisional Agreements reached with REM, PHARMAC has decided to list the medical devices in Part III of […]
Read More →Decision to list or amend medical devices supplied by Boucher & Muir (NZ) Ltd
Source: Pharmac What we are doing We’re pleased to announce PHARMAC has made a decision to approve an agreement* with Boucher & Muir (NZ) Ltd for the supply of its insulin pen needle devices. The effect of the decision is that: from 1 June 2019 Boucher & Muir’s 31G x 6 mm insulin pen needle […]
Read More →